Macquarie Group’s Celestica CLS Stock Holding History

Macquarie Group’s Portfolio CLS Stock Details CLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-29,000	Closed	-$6.17M	–	1616
2025 Q2	$6.17M	Buy	29,000 +12,611	+77%	+$1.34M	0.01%	933
2025 Q1	$1.86M	Buy	+16,389	New	+$1.74M	﹤0.01%	1246

Other funds holding CLS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

WRCM

Whale Rock Capital Management Boston, Massachusetts $12.5B AUM 306.52% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Macquarie Group's CLS Position: Q3 2025 in Review

Macquarie Group sold out of Celestica (CLS) in Q3 2025, closing a stake of 29,000 shares — an estimated $6.17M sold.

Macquarie Group first reported a position in CLS in Q1 2025 and held it in 2 quarters. The position peaked at $6.17M in Q2 2025. 712 funds tracked by Wall St. Rank hold CLS as of Q3 2025.

Macquarie Group reported no remaining Celestica position as of Q3 2025 after selling out during the quarter.
Macquarie Group sold 29,000 Celestica shares in Q3 2025, an estimated $6.17M.
Macquarie Group first reported a position in Celestica in Q1 2025 and held it in 2 quarters.
Macquarie Group's Celestica position peaked at $6.17M in Q2 2025.
712 funds tracked by Wall St. Rank held Celestica as of Q3 2025.

Based on Macquarie Group's 13F filing for Q3 2025, filed 13 Nov 2025.